Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (8)

2024

  1. RET Fusion Testing in Patients With NSCLC: The RETING Study

    JTO Clinical and Research Reports, Vol. 5, Núm. 4

2022

  1. Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Lung Cancer in Spain

    Journal of Thoracic Oncology

  2. Pan-TRK immunohistochemistry an example-based practical approach to efficiently identify patients with NTRK fusion cancer

    Archives of Pathology and Laboratory Medicine, Vol. 145, Núm. 8, pp. 1031-1040

2020

  1. A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens

    Cancer Cytopathology, Vol. 128, Núm. 12, pp. 928-938

  2. Cystic brain metastases revealed patient with RET-rearranged non–small-cell lung cancer with leptomeningeal carcinomatosis and RET-positive in CSF

    JCO Precision Oncology, Vol. 4

2019

  1. FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

    Journal of Thoracic Oncology, Vol. 14, Núm. 4, pp. 641-655

2018

  1. Aligning digital CD8 + scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma

    Histopathology, Vol. 72, Núm. 2, pp. 270-284